作者: Takashi Himoto , Mikio Nishioka
DOI: 10.1007/S13317-013-0046-7
关键词: Anti-SSA/Ro autoantibodies 、 Hepatitis 、 Primary biliary cirrhosis 、 Anti-thyroid autoantibodies 、 Liver disease 、 Autoimmune hepatitis 、 Alcoholic liver disease 、 Immunology 、 Medicine 、 Primary sclerosing cholangitis
摘要: It has been well established that numerous kinds of autoantibodies have detected in liver disease. Some may be helpful the diagnosis autoimmune diseases including hepatitis, primary biliary cirrhosis or sclerosing cholangitis. However, these are present even sera patients with viral drug-induced alcoholic disease, non-alcoholic fatty disease and hepatocelluar carcinoma as diseases. Other recognized predictive hallmarks for activity prognosis On other hand, treatment interferon initiates production several types chronic hepatitis C virus infection. induced by postulate outcome those patients. Recent studies also revealed close correlation between oxidative stress This article primarily reviews recent advances discusses clinical significance autoantibodies.